Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anirudh Bakshi & Samy Suissa. (2021) Effectiveness of Aspirin in COPD: Biases in the Observational Studies. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:4, pages 449-455.
Read now
Read now
Peter Alter, Barbara A Mayerhofer, Kathrin Kahnert, Henrik Watz, Benjamin Waschki, Stefan Andreas, Frank Biertz, Robert Bals, Claus F Vogelmeier & Rudolf A Jörres. (2019) Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2163-2172.
Read now
Read now
Articles from other publishers (7)
Qiang Zheng, Petr Otahal, Ingrid A. Cox, Barbara de Graaff, Julie A. Campbell, Hasnat Ahmad, E. Haydn Walters & Andrew J. Palmer. (2023) The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study. Frontiers in Medicine 10.
Crossref
Crossref
Mohammed Ruzieh, Aaron D Baugh, Lama Al Jebbawi, Emily S Edwards, Kelly Qi Jia, Mark T Dransfield & Andrew J Foy. (2023) Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review. Trends in Cardiovascular Medicine 33:1, pages 53-61.
Crossref
Crossref
Allison Martin, Robert J Hancox, Catherina L Chang, Richard Beasley, Jeremy Wrobel, Vanessa McDonald, Claudia C Dobler, Ian A Yang, Claude S Farah, Belinda Cochrane, Graham S Hillis, Caroline Polak Scowcroft, Ashutosh Aggarwal, Gian Luca Di Tanna, Grace Balicki, Shane Galgey & Christine Jenkins. (2021) Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD. BMJ Open 11:8, pages e053446.
Crossref
Crossref
Fernando Sergio Leitao Filho, Lauren Choi & Don D. Sin. (2021) Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly. Current Opinion in Pulmonary Medicine 27:2, pages 125-131.
Crossref
Crossref
Mark T. Dransfield, Helen VoelkerSurya P. BhattKeith BrennerRichard CasaburiCarolyn E. ComeJ. Allen D. CooperGerard J. CrinerJeffrey L. CurtisMeiLan K. HanUmur HatipoğluErika S. HelgesonVipul V. JainRavi Kalhan, David KaminskyRobert KanerKen M. KunisakiAllison A. LambertMatthew R. LammiSarah LindbergBarry J. MakeFernando J. MartinezCharlene McEvoyRalph J. PanosRobert M. ReedPaul D. ScanlonFrank C. SciurbaAnthony SmithPeruvemba S. SriramWilliam W. StringerJeremy A. WeingartenJ. Michael WellsElizabeth WestfallStephen C. LazarusJohn E. Connett. (2019) Metoprolol for the Prevention of Acute Exacerbations of COPD. New England Journal of Medicine 381:24, pages 2304-2314.
Crossref
Crossref
Tracey L. Mersfelder & Dane L. Shiltz. (2019) β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations. Annals of Pharmacotherapy 53:12, pages 1249-1258.
Crossref
Crossref
Shan Jiang, Nabjian Mohammadtursun, Jian Qiu, Qiuping Li, Jing Sun & Jingcheng Dong. (2019) Recent advances on animal models related to chronic obstructive pulmonary disease. Traditional Medicine and Modern Medicine 02:03, pages 93-104.
Crossref
Crossref